A examine revealed in Lancet highlights the protection and effectiveness of rabies therapy Rabishield. Credit score: UMass Chan file picture
Rabies is among the deadliest infectious ailments, however it is usually preventable when handled rapidly after an animal chunk. A brand new post-licensure scientific examine revealed in The Lancet additional demonstrates that Rabishield, a monoclonal antibody remedy developed by UMass Chan Medical College in partnership with the Serum Institute of India, presents a protected and efficient different to older rabies therapies.
In 2017, the Serum Institute of India introduced the worldwide launch of Rabishield, a U.S.-patented product, in an effort to shut the gaps in rabies prevention and scale back the rabies mortality charge in India. Rabies is a deadly viral illness brought on by the chunk or scratch of an contaminated animal. Whereas it’s hardly ever deadly in the US, worldwide it kills greater than 50,000 individuals a 12 months who typically do not have entry to the therapy they want. In India, it kills an estimated 20,000 individuals yearly—two individuals each hour.
Within the new examine, greater than 4,000 sufferers in India who had high-risk animal bites obtained both Rabishield plus a rabies vaccine or the normal equine rabies immunoglobulin plus vaccine. Each teams developed sturdy immune responses, however Rabishield was higher tolerated, with fewer severe unwanted effects. Importantly, no members developed rabies throughout a 12 months of follow-up.
“This study reinforces Rabishield’s role in expanding global access to lifesaving rabies post-exposure treatment, particularly in countries where rabies remains a significant public health threat,” stated Mark Klempner, MD, professor of medication and chief of the analysis crew that developed the therapy.
Extra info:
Prasad S Kulkarni et al, Submit-exposure prophylaxis routine of rabies monoclonal antibody and vaccine in class 3 potential publicity sufferers: a part 4, open-label, randomised, active-controlled trial, The Lancet (2025). DOI: 10.1016/s0140-6736(25)00735-4
Supplied by
College of Massachusetts Medical College
Quotation:
Examine highlights monoclonal antibody remedy as protected and efficient in stopping rabies (2025, September 26)
retrieved 26 September 2025
from https://medicalxpress.com/information/2025-09-highlights-monoclonal-antibody-therapy-safe.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
